著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Max Jan and Adam S. Sperling and Benjamin L. Ebert,Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide,Nature Reviews Clinical Oncology,1759-4774,Springer Science and Business Media LLC,2021-03-02,18,7,401-417,https://cir.nii.ac.jp/crid/1360857595848669824,https://doi.org/10.1038/s41571-021-00479-z